| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 02/01/2005 | US6849394 Compositions comprising reproductive cell media and methods for using such compositions |
| 02/01/2005 | US6849279 Glycoprotein; solvent extraction; prevention pollution, ultraviolet radiation damage |
| 02/01/2005 | US6849269 Enteric-coated mixture of a poorly water soluble drug and a phospholipid |
| 02/01/2005 | US6849257 Comprises catalytic or stoichiometric lipid removal, wherein proteins and/or polypeptides (lysosoymal acid lipase) target receptors in and/or on the cell which lead to uptake into the lysosome |
| 02/01/2005 | US6849256 Inhibition of pathogens by probiotic bacteria |
| 02/01/2005 | US6849255 Administering a cell that expresses at least one factor of the T-box family, such as brachyury. |
| 01/27/2005 | WO2005008253A2 Stable compositions for measuring human natriuretic peptides |
| 01/27/2005 | WO2005007861A2 Method for the production and use of antimicrobial protein-inducing factors obtained from gram-negative bacteria |
| 01/27/2005 | WO2005007849A1 Method of enhancing alkylating drug sensitivity |
| 01/27/2005 | WO2005007839A1 METHOD OF PREPARING LANGERHANS CELL FROM CD14-POSITIVE CELL BEING HUMAN PERIPHERAL-BLOOD MONONUCLEAR CELL WITH USE OF NOTCH LIGAND DELTA-1, GM-CSF AND TGF-β |
| 01/27/2005 | WO2005007836A1 Regulatory t-cells containing galectins for the therapy and diagnosis of diseases |
| 01/27/2005 | WO2005007835A1 Methods of preparing a transplantable product for treatment of skin defects |
| 01/27/2005 | WO2005007834A1 Acid tolerant probiotic lactobacillus plantarum probio-38 that can suppress the growth of pathogenic microorganism and tge coronavirus |
| 01/27/2005 | WO2005007832A2 System for external control of oncolytic virus replication |
| 01/27/2005 | WO2005007811A2 Injection of bone marrow-derived cells and medium for angiogenesis |
| 01/27/2005 | WO2005007797A2 Oligodendrocyte precursor cells and methods of obtaining and culturing the same |
| 01/27/2005 | WO2005007199A1 COMPOUNDS AND METHODS FOR DOWNREGULATING THE EFFECTS OF TGF-β |
| 01/27/2005 | WO2005007179A1 Composition containing ground lotus and/or lotus extract and lactic acid bacterium |
| 01/27/2005 | WO2005007178A1 Treatment of malodour |
| 01/27/2005 | WO2005007177A1 Pharmaceutical agent against stomach ulcers |
| 01/27/2005 | WO2005007176A1 Remedy for internal administration against cranial nerve diseases containing mesenchymal cells as the active ingredient |
| 01/27/2005 | WO2005007175A2 Cadherin directed molecular and cellular localization |
| 01/27/2005 | WO2005007073A2 Ex vivo progenitor and stem cell expansion for use in the treatment of disease of endodermally-derived organs |
| 01/27/2005 | WO2005006891A1 Carbohydrate substitute |
| 01/27/2005 | WO2005006861A2 Double dye method to inactivate blood borne pathogens |
| 01/27/2005 | WO2004104492A3 Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same |
| 01/27/2005 | WO2004100967A3 Preparation containing animal bile |
| 01/27/2005 | WO2004084950A3 Cell targeting methods and compositions |
| 01/27/2005 | WO2004084927A3 Compositions for inducing of immunotolerance |
| 01/27/2005 | US20050020519 Increase concentration of peptide; controlling glucose uptake into cells; adjust metabolism; stimulate cell proliferation; reduce apoptosis; moderate gene expression' |
| 01/27/2005 | US20050020490 Eficiency purification of glucan, mannan, mannan-protein complex from yeasts; reducing antibiotics in animal feeds |
| 01/27/2005 | US20050019921 Method for combined sequential agent delivery and electroporation for cell structures and use thereof |
| 01/27/2005 | US20050019911 Used to augment bone marrow transplantation; drug delivery, gene therapy |
| 01/27/2005 | US20050019909 Modified retinal pigment epithelial cells for cell transplantation |
| 01/27/2005 | US20050019908 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 01/27/2005 | US20050019894 used to treat probiotic infectious diarrhea caused by pathogenic microorganisms, gastroenteritis, inflammatory intestinal disease, neurological intestinitis syndrome, overgrowth of small intestinal microorganisms and intestinal feeding diarrhea. |
| 01/27/2005 | US20050019872 PC-LECTIN protein; vaccines and diagnostic marker for prostate cancer |
| 01/27/2005 | US20050019865 Cartilage and bone repair and regeneration using postpartum-derived cells |
| 01/27/2005 | US20050019754 Peptides of given sequence with immunogenic epitopes activating CD8+ class I major histocompatibility complex restricted cytotoxic T-lymphocytes for patients harboring latent HCMV infection in the absence of active viral replication; using enriched antigen presenting cells; vaccines |
| 01/27/2005 | US20050019743 Improved blood product suitable for use in transfusions comprising inhibitor of glycoprotein Ib alpha cleavage, such as a metalloproteinase or TACE inhibitor |
| 01/27/2005 | US20050019418 Wart treatment |
| 01/27/2005 | US20050019417 stabilization of proteins, peptides or cells by fluidization of microparticles to form fluidized bed of microparticles comprising water soluble gel forming solid particles, then spraying coating with liquids comprising sugars and solvents, and drying |
| 01/27/2005 | US20050019410 dissolving particles in solvents and then precipitation by mixing the solutions with nonsolvents and spray drying to form microstructure particles; imaging contrast enhancing agents used for medical diagnosis |
| 01/27/2005 | US20050019370 Drug delivery device containing viable cells implanted into blood vessel; cells produce and secrete the pre-selected molecule into systemic circulation; capsule held in place by anchored blood permeable element |
| 01/27/2005 | US20050019344 Antigens; vaccines; isolated peptide |
| 01/27/2005 | US20050019313 Genetic engineering; supplying stem cells; genes code cytosine deaminase; central nervous system tumors |
| 01/27/2005 | US20050019311 For biological particles; encapsulated active materials |
| 01/27/2005 | US20050019310 Method for culturing and expansion of mammalian undifferentiated epidermal kerainocytes exhibiting stem cell characteristics |
| 01/27/2005 | US20050019308 Administering reovirus; lysis of cancer cells |
| 01/27/2005 | US20050019307 Therapy gene against mammary gland cancer; transcription control ; Dna |
| 01/27/2005 | DE10330712A1 Pharmarzeutischer Wirkstoff gegen Kolonkarzinome und andere Tumorarten Pharmarzeutischer agent against colon cancer and other tumor types |
| 01/27/2005 | CA2535034A1 Internallly administered therapeutic agents for diseases in central and peripheral nervous system comprising mesenchymal cells as an active ingredient |
| 01/27/2005 | CA2533121A1 Method of preparing langerhans cell from cd14-positive cell being human peripheral-blood mononuclear cell with use of notch ligand delta-1, gm-csf and tgf-.beta. |
| 01/27/2005 | CA2532630A1 Use of lymphocytes transformed with .alpha.-2-heremans-schmid glycoprotein (ahsg) to treat tgf-.beta.-mediated cancer |
| 01/27/2005 | CA2532216A1 Oligodendrocyte precursor cells and methods of obtaining and culturing the same |
| 01/27/2005 | CA2532138A1 Injection of bone marrow-derived cells and medium for angiogenesis |
| 01/27/2005 | CA2532127A1 Regulatory t-cells containing galectins for the therapy and diagnosis of diseases |
| 01/27/2005 | CA2516652A1 System for external control of oncolytic virus replication |
| 01/26/2005 | EP1499886A1 Methods and compositions for inducing an immune response |
| 01/26/2005 | EP1499840A1 Container for transporting biological material |
| 01/26/2005 | EP1499736A1 Improved chimeric glycoproteins and pseudotyped lentiviral vectors |
| 01/26/2005 | EP1499735A2 Optimization of transgene expression in mammalian cells |
| 01/26/2005 | EP1499710A2 Method for growth of human conjunctival tissue equivalents for research, clinical ocular surface transplantation and tissue engineering |
| 01/26/2005 | EP1499707A2 Enhancement of hematopoietic stem cell survival |
| 01/26/2005 | EP1499633A2 Hagfish cathelin-associated antimicrobial peptides and genes |
| 01/26/2005 | EP1499347A2 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs |
| 01/26/2005 | EP1499332A2 Compositions and methods for treating cancer with an oncolytic viral agent |
| 01/26/2005 | EP1499288A1 Apparatus and method for delivery of bacteria to the vaginal tract |
| 01/26/2005 | EP1499190A2 Methods for treating liver disease and liver damage with growth hormone and foxm1b |
| 01/26/2005 | EP1499181A2 Vascularized human skin equivalent |
| 01/26/2005 | EP1468094A4 Method of transducing es cells |
| 01/26/2005 | EP1446476A4 Endothelial cells derived from primate embryonic stem cells |
| 01/26/2005 | EP1383889A4 Modified organs and cells for xenotransplantation |
| 01/26/2005 | EP1334177B1 Generation and use of dendritic cells |
| 01/26/2005 | EP1283047A4 Method for producing a bioactive substance from blood serum |
| 01/26/2005 | EP1239867B1 Methods for treating and preventing damage to mucosal tissue |
| 01/26/2005 | EP1185279B1 Agents for treating malignant diseases using e1a-deficient adenoviruses with yb-1 protein-dependent replication |
| 01/26/2005 | EP1061950B1 Live vaccine for human immunodeficiency virus |
| 01/26/2005 | EP1058563B1 Systems for obtaining a uniform targeted volume of concentrated red blood cells |
| 01/26/2005 | EP0996636B1 The ha-1 antigen |
| 01/26/2005 | EP0769968B1 Retroviral vectors produced by producer cell lines resistant to lysis by human serum |
| 01/26/2005 | EP0725826B1 Improvements relating to cancer therapy |
| 01/26/2005 | CN1571835A Keratinocytes which may be used as biologically active substances for the treatment of wounds |
| 01/26/2005 | CN1571834A Cell therapy method for the treatment of tumors |
| 01/26/2005 | CN1571658A Pharmaceutical formulation comprising (R)-bicalutamide |
| 01/26/2005 | CN1570122A Adenovirus vector for idiopathy liver genetherapy and using method |
| 01/26/2005 | CN1570091A Recombinant 1 type herpes simplex virus and its preparation method and uses |
| 01/26/2005 | CN1569245A Method for eliminating antigen from animal fur |
| 01/26/2005 | CN1569236A Implantable pouch seeded with insulin-producing cells to treat diabetes |
| 01/26/2005 | CN1569218A Bone peptide for injection and its preparation method |
| 01/26/2005 | CN1569044A Healthy product raw liquor of armilariella tabescens for strengthening the body and protecting the liver and method for improving the formulation of armilariella tabescens |
| 01/26/2005 | CN1569043A Coated micro capsule of lactic acid bacteria and its preparation |
| 01/26/2005 | CN1569042A Preparing and assaying method of staphylococcus aureus filtrate preparation |
| 01/26/2005 | CN1569041A Pharmaceutical composition capable of resisting cancer and easing pain |
| 01/26/2005 | CN1569040A Hypercritical soluble propolis prescription and its preparing method |
| 01/26/2005 | CN1569039A Powder for treating hyperosteogeny and protrusion of lumber and spondylopathy intervertebral disc and its preparation |
| 01/26/2005 | CN1569038A Medicine for treating knife wound and other wounds and its preparation |
| 01/26/2005 | CN1569037A Medicine for treating burns and scalds and its preparation method |
| 01/26/2005 | CN1569036A Medicine for treating cindyloma acuminatum and its preparing process |
| 01/26/2005 | CN1569035A Manufacturing method of biological protein calcium with metal sulfur protein |